- Home
- AIRTP vs OSRHW Comparison
AIRTP vs OSRHW Comparison
Compare AIRTP & OSRHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AIRTP | OSRHW |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | 646 | 22 |
| Industry | Air Freight/Delivery Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | AIRTP | OSRHW |
|---|---|---|
| Price | $19.18 | $0.04 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.3K | ★ 41.4K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.28 | $0.03 |
| 52 Week High | $21.00 | $0.08 |
Technical Indicators
Market Signals| Indicator | AIRTP | OSRHW |
|---|---|---|
| Relative Strength Index (RSI) | 49.85 | 42.14 |
| Support Level | $18.96 | $0.04 |
| Resistance Level | $19.36 | $0.06 |
| Average True Range (ATR) | 0.23 | 0.01 |
| MACD | 0.05 | -0.00 |
| Stochastic Oscillator | 80.60 | 33.22 |
Price Performance
Historical ComparisonAbout AIRTP Air T Inc. Air T Funding Alpha Income Trust Preferred Securities
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include Overnight air cargo, Ground equipment sales, Commercial jet engines, and parts, Corporate, and Others. The company generates maximum revenue from the Commercial Jet Engines and Parts segment.
About OSRHW OSR Holdings Inc. Warrant
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.